<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230205057324N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-03-11</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Immediate effect of hip abductor muscles kinesio taping on static and dynamic balance before and after muscular fatigue induction in elderly people</public_title>
      <acronym>KT = kinesiotape</acronym>
      <scientific_title>Immediate effect of hip abductor muscles kinesio taping on static and dynamic balance before and after muscular fatigue induction in elderly people</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-03-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>26</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68447</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Other, Purpose: Prevention, Randomization description: Randomization will be based on a single sequence (simple randomization) and the random number table method will be used, so that the table is read from the above and even numbers are considered for the intervention group (Kinesio taping with tension) and odd numbers are for the control group. allocation concealment will be done using sealed opaque envelopes and each of the random sequences will be recorded on a card and the cards will be placed inside the envelopes. In the end, after gluing the lid of the envelopes they will be placed inside a box. 26 envelopes will be placed inside the box. at the beginning of the study, one of the envelopes will be opened in order and the assigned group for each participant will be revealed, Blinding description: Participants will be aware of the method of taping being used on them, but they will not be aware of which group they have been allocated to. Participants are not aware of how the KT is used for the other group. Participants will not meet each other.
The evaluating researcher does not know which group the participants belong to and a comfortable wearing hides the region in which KT is applied.
The data analyzer is blinded for the Sham or Intervention group and knows the groups by the name 1 and 2.</study_design>
      <phase>N/A</phase>
      <hc_freetext>-.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Gluteus Medius excitatory taping method was used for the intervention group. 2 I shaped tapes in which only the middle third was held in 35% tension was attached to the skin, one from the anterior part of the Iliac crest to the greater trochanter of the femur, and the other from the posterior part of the iliac crest to the greater trochanter of the femur. tape length was measured for each individual separately. Messon KT made in China was utilized in this study. In this brand of KT, in a 10-centimeter cut of tape, when held in 35% tension, a 2-centimeter increase in length happens. Intervention 2: Control group: only one I shape piece of KT with no tension in horizontal direction will be placed in the lateral side of hip joint, on the skin of abductor muscles region.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be available after unidentification.

When:
The access period starts 3 months after the article is published

To whom:
For researchers working in academic, scientific and hospital institutions.

Conditions:
Researchers working in the field of elderly rehabilitation

Where to obtain:
Applicants could contact Mr. Rezvani via E-mail: pt.rezvani@gmail.com

How to obtain:
After identification of the aplicant, the data will be sent to their mail.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohsen Rezvani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 179, Somayye Ave, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۵۸۱۷۴۹۷۱۱</zip>
        <telephone>+98 51 4221 8531</telephone>
        <email>pt.rezvani@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nastaran Ghotbi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of rehabilitation, Piche-Shemiran, Enghelab Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7752 8468</telephone>
        <email>nghotbi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>age between 60 and 75 years old
independence for using instrumental aids
independence for activities of daily living
normal or controlled blood pressure with medicine</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>decompensated Heart Failure
neurologic diseases or conditions such as MSA, TBI, CVA, MS and CP
presence of muscular dysfunctions such as myopathies, fibrositis and MG
presence of dizziness
complains of visual problems which interfere with balance control
history of knee or hip arthroplasty surgery
presence of unconsolidated fractures
diabetes mellitus interfering with detection of application in the soles of the feet
presence of open wounds in lower limbs
presence of unhealed scar tissues in the region of applying KT</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Gluteus Medius excitatory taping method was used for the intervention group. 2 I shaped tapes in which only the middle third was held in 35% tension was attached to the skin, one from the anterior part of the Iliac crest to the greater trochanter of the femur, and the other from the posterior part of the iliac crest to the greater trochanter of the femur. tape length was measured for each individual separately. Messon KT made in China was utilized in this study. In this brand of KT, in a 10-centimeter cut of tape, when held in 35% tension, a 2-centimeter increase in length happens.</i_keyword>
      <i_keyword>Control group: only one I shape piece of KT with no tension in horizontal direction will be placed in the lateral side of hip joint, on the skin of abductor muscles region.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Single leg stance time. Timepoint: Baseline assessment, after applying KT, after inducing muscle fatigue. Method of measurement: stopwatch.</prim_outcome>
      <prim_outcome>Reached distances in Star Excursion Balance Test. Timepoint: Baseline assessment, after applying KT, after inducing muscle fatigue. Method of measurement: tape measure.</prim_outcome>
      <prim_outcome>Maximum gait speed. Timepoint: Baseline assessment, after applying KT, after inducing muscle fatigue. Method of measurement: utilization of speed measurement formula (distance divided by time).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-01</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>No. 179, Somayyeh Ave, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
